Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant

Journal of Molecular Biology

Volumn 285, Issue 5, 1999, Pages 2089-2104

  Zhang, Erli ^a   St Charles, Robert ^a   Tulinsky, A ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Kunitz domains; Multi domain enzymes; Ternary protein complex; Tissue factor pathway inhibitor

Indexed keywords

ARGININE; ASPARTIC ACID; BLOOD CLOTTING FACTOR 7A; LYSINE; MUTANT PROTEIN; THROMBOPLASTIN; TYROSINE;

AMINO ACID SEQUENCE; ARTICLE; ENZYME ACTIVE SITE; GENETIC ENGINEERING; HYDROGEN BOND; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

EID: 0033524955     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.2452     Document Type: Article

References (69)

1. Bajaj S. P., Sabharwal A. K., Gorka J., Birktoft J. J. Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation. Proc. Natl Acad. Sci. USA. 89:1992;152-156.
2. Banner D. W., D'Arcy A., Chene C., Winkler F. K., Guha A., Konigsberg W. H., Nemerson Y., Kirchhofer D. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 380:1996;41-46.
3. 1NMR assignment and secondary structure of the cell adhesion type III module of fibronectin. Biochemistry. 31:1992;2068-2073.
4. Bharadwaj D., Iino M., Kontoyianni M., Smith K. J., Foster D. C., Kisiel W. Factor VII Central. J. Biol. Chem. 271:1996;30685-30691.
5. Bjoern S., Foster D. C., Thim L., Wiberg F. C., Christensen M., Komiyama Y., Pedersen A., Kisiel W. Human plasma and recombinant factor VII. Characterization of O -glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis on serine 52 to alanine. J. Biol. Chem. 266:1991;11051-11057.
6. Bode W., Schwager P. The refined crystal structure of bovine β-trypsin at 1.8 Å resolution. J. Mol. Biol. 98:1975;693-717.
7. Bode W., Turk D., Karshikov A. The refined 1.9-Å X-ray crystal structure of D -Phe-Pro-Arg chloromethylketone-inhibited human α-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci. 1992;1426-1471.
8. Brandstetter H., Bauer M., Huber R., Lollar P., Bode W. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. Proc. Natl Acad. Sci. USA. 92:1995;9796-9800.
9. Broze G. J. Jr, Girard T. J., Novotny W. F. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry. 29:1990;7539-7546.
10. Brunger A. T. A system for X-ray crystallography and NMR. X-PLOR Manual Version 3.1. 1993;Yale University, New Haven.
11. Burgaring M. J. M., Orbons L. P. M., van der Doelen A., Mulders J., Theunissen H. J. M., Grootenhuis P. D. J., Bode W., Huber R., Stubbs M. T. The second Kunitz domain of human tissue factor inhibitor. J. Mol. Biol. 269:1997;395-407.
12. Davie E. W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 30:1991;10363-10370.
13. Dennis M. S., Lazarus R. A. Kunitz domain inhibitors of tissue factor-Factor VIIa. J. Biol. Chem. 269:1994;22137-22144.
14. Dickinson C. D., Kelly C. R., Ruf W. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc. Natl Acad. Sci. USA. 93:1996;14379-14384.
15. Fisher K. L., Gorman C. M., Vehar G. A., O'Brien D. P., Lawn R. M. Cloning and expression of human tissue factor cDNA. Thrombosis Res. 48:1987;89-99.
16. Ganesh V., Lee A. Y., Clardy J., Tulinsky A. Comparison of the structures of cyclotheonamide A complexes of human α-thrombin and β-bovine trypsin. Protein Sci. 5:1996;825-835.
17. Hardy J. F., Desroches J. Natural and synthetic anti-fibrinolytics in cardiac surgery. Can. J. Cardiol. 39:1992;353-365.
18. Harlos K., Martin D. M. A., O'Brien D. P., Jones E. Y., Stuart D. I., Pollkarpov I., Miller A., Tuddenham E. G. D., Boys C. W. G. Crystal structure of the extracellular region of human tissue factor. Nature. 370:1994;662-666.
19. Hendrickson W. A. Stereochemically restrained refinement of macromolecular structure. Methods Enzymol. 115:1985;252-270.
20. Higuchi D. A., Wun T. C., Likert K. M., Broze G. J. Jr. The effect of leukocyte elastase on tissue factor pathway inhibitor. Blood. 79:1992;1712-1719.
21. Huang M., Syed R., Stura E. A., Stone M. J., Stefanko R. S., Ruf W., Edgington T. S., Wilson I. A. The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF·5G9 complex. J. Mol. Biol. 275:1998;873-894.
22. Huber R., Kukla D., Bode W., Schwager P., Bartels K., Deisenhofer J., Steigemann W. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. J. Mol. Biol. 89:1974;73-101.
23. Ichinose A., Davie E. W. The blood coagulation factors. Colman R. W., Hirsch J., Marder V. J., Salzman E. W. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 1994;19-54 J. B. Lippincott Co. Philadelphia.
24. Kelly C. R., Schullek J. R., Ruf W., Edgington T. S. Tissue factor residue Asp44 regulates catalytic function of the bound proteinase factor VIIa. Biochem. J. 315:1996;145-151.
25. +2binding to the first epidermal growth factor module of coagulation factor VIIa is important for cofactor interaction and proteolytic function. J. Biol. Chem. 272:1997;17467-17472.
26. Kirchhofer D., Guha A., Nemerson Y., Konigsberg W. H., Vilbois F., Chene C., Banner D. W., D'Arcy A. Activation of blood coagulation factor VIIa with cleaved tissue factor extracellular domain and crystallization of the active complex. Proteins: Struct. Funct. Genet. 22:1995;419-425.
27. Krishnan R., Zhang E., Hakansson K., Arni R. K., Tulinsky A., Lim-Wilby M. S. L., Levy O. D., Semple J. E., Brunck T. K. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes. Biochemistry. 37:1998;12094-12103.
28. Leahy D. J., Hendrickson W. A., Aukhil I., Erickson H. P. Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein. Science. 258:1992;987-991.
29. Martin D. M. A., Boys C. W. G., Ruf W. Tissue factor: molecular recognition and cofactor function. FASEB J. 9:1995;852-859.
30. Mather T., Oganessyan V., Hof P., Huber R., Foundling S., Esmon C., Bode W. The 2.8 Å crystal structure of Gla-domainless activated protein C. EMBO J. 15:1996;6822-6831.
31. Matthews J. H., Krishnan R., Costanzo M. J., Maryanoff B. E., Tulinsky A. Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1′ binding site. Biophys. J. 71:1996;2830-2839.
32. Morrissey J. H., Fakhrai H., Edgington T. S. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell. 50:1987;129-135.
33. Muller Y. A., Ultsch M. H., Kelley R. F., de Vos A. M. Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site. Biochemistry. 33:1994;10864-10870.
34. Muller Y. A., Ultsch M. H., de Vos A. M. The crystal structure of the extracellular domain of human tissue factor refined to 1.7 Å resolution. J. Mol. Biol. 256:1996;144-159.
35. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A. 50:1994;157-163.
36. Nemerson Y. Tissue factor and hemostasis. Blood. 71:1988;1-8.
37. Orthner C. L., Kosow D. P. The effect of metal ions on the amidolytic activity of human factor Xa. Arch. Biochem. Biophys. 185:1978;400-406.
38. Orthner C. L., Kosow D. P. Evidence that human α-thrombin is a monovalent cation-activated enzyme. Arch. Biochem. Biophys. 202:1980;63-75.
39. Osterud B., Rapaport S. I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc. Natl Acad. Sci. USA. 74:1977;5260-5264.
40. Padmanabhan K., Padmanabhan K. P., Tulinsky A., Park C. H., Bode W., Huber R., Blankenship D. T., Cardin A. D., Kisiel W. Structure of human des (1-45) factor Xa at 2.2 Å resolution. J. Mol. Biol. 232:1993;947-966.
41. Perona J. J., Tsu C., Craik C. S., Fletterick R. J. Crystal structures of rat anionic trypsin complexed with the protein inhibitors APPI and BPTI. J. Mol. Biol. 230:1993;919-933.
42. +2binding on the protease module of factor Xa and its interaction with factor Va. J. Biol. Chem. 268:1993;22531-22539.
43. Petersen L. C., Bjorn S. E., Nordfang O. Effect of leukocyte proteinases on tissue factor pathway inhibitor. Thrombosis Haemostasis. 67:1992;537-541.
44. Petersen L. C., Bjorn S. E., Olsen O. H., Nordfang O., Norris F., Norris K. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway-inhibitor. Eur. J. Biochem. 235:1996;310-316.
45. Rao L. V. M., Rapaport S. I. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc. Natl Acad. Sci. USA. 85:1988;6687-6691.
46. Rao L. V. M., Ruf W. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor·VIIa with Xa·tissue factor pathway inhibitor. Biochemistry. 34:1995;10867-10871.
47. +2-binding epidermal growth factor-like domain: its role in protein-protein interactions. Cell. 82:1995;131-141.
48. Rapaport S. Inhibition of factor VIIa/tissue factor-induced blood coagulation with particular emphasis upon a factor Xa-dependent inhibitory mechanism. Blood. 73:1989;359-365.
49. Ripka W., Brunck T., Stanssens P., LaRoche Y., Lauwereys M., Lambeir A-M., Lasters I., De Maeyer M., Vlasuk G., Levy O., Miller T., Webb T., Tamura S., Pearson D. Strategies in the design of inhibitors of serine proteases of the coagulation cascade: factor Xa. Eur. J. Med. Chem. 30:1995;87-100.
50. +2-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activity. J. Biol. Chem. 270:1995;15523-15530.
51. Scarpati E. M., Wen D., Broze G. J., Miletich J. P., Flandermeyer R. R., Siegel N. R., Sadler J. E. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry. 26:1987;5234-5238.
52. +2ion binding sites in factor VIIa and in des(1-38) factor VIIa. FEBS Letters. 306:1992;265-268.
53. Selander-Sunnerhagen M., Ullner M., Persson E., Teleman O., Stenflo J., Drakenberg T. How an epidermal growth factor (EGF)-like domain binds calcium. J. Biol. Chem. 267:1992;19642-19649.
54. Seshadri T. P., Tulinsky A., Skrzypczak-Jankun E., Park C. H. Structure of bovine prothrombin fragment 1 refined at 2.25 Å resolution. J. Mol. Biol. 220:1991;481-494.
55. Silverberg S. A., Nemerson Y., Zur M. Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. J. Biol. Chem. 252:1977;8481-8488.
56. +2-prothrombin fragment 1. Biochemistry. 31:1992;2554-2566.
57. Spicer E. K., Horton P., Bloem L., Bach R., Williams K. R., Guha A., Kraus J., Lin T. C., Nemerson Y., Konigsberg W. H. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc. Natl Acad. Sci. USA. 84:1987;5148-5152.
58. Stassen J. M., Lambeir A-M., Matthyssens G., Ripka W. C., Nystrom A., Sixma J. J., Vermylen J. Characterization of a novel series of aprotinin-derived anticoagulants. Thrombosis Haemostasis. 74:1995;646-654.
59. St. Charles R. S., Matthews J. H., Zhang E., Tulinsky A. The bound structures of novel P3-P1′ β-strand mimetic inhibitors of thrombin. J. Med. Chem. 1999.
60. Steiner S. A., Castellino F. J. Kinetic studies of the role of monovalent cations in amidolytic activity of activated bovine plasma protein C. Biochemistry. 21:1982;4609-4614.
61. Strickland D. K., Castellino F. J. The binding of calcium to bovine factor VII. Arch. Biochem. Biophys. 190:1980;687-692.
62. Stura E. A., Wilson L. A., Ruf W. Crystallization and preliminary crystallographic data for a ternary complex between tissue factor, factor VIIa and a BPTI-derived inhibitor. J. Crystal Growth. 168:1996;260-269.
63. +2binding to the first EGF domain. Biochemistry. 35:1996;11547-11559.
64. van de Locht A., Bode W., Huber R., Le Bonniec B. F., Stone S. R., Esmon C. T., Stubbs M. T. The thrombin E192Q:BPTI complex reveals gross structural rearrangements. EMBO J. 16:1997;2977-2984.
65. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 29:1985;236-261.
66. Weber P. C., Lee S.-L., Lewandowski F. A., Schadt M. C., Chang C.-H., Kettner C. A. Kinetic and crystallographic studies of thrombin with Ac-(D)Phe-Pro-boroArg-OH and its lysine, amidine, homolysine and ornithine analogs. Biochemistry. 34:1995;3750-3757.
67. +-activated enzyme. Biochemistry. 31:1992;11721-11730.
68. Wesselschmidt R., Likert K., Girard T. J., Wun T. C., Broze G. J. Jr. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. Blood. 79:1992;2004-2010.
69. +binding site of thrombin. Biophys. Chem. 63:1997;185-200.